These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 3116494)
1. The cholesteryl octanoate breath test: a new procedure for detection of pancreatic insufficiency in the rat. Mundlos S; Rhodes JB; Hofmann AF Pediatr Res; 1987 Sep; 22(3):257-61. PubMed ID: 3116494 [TBL] [Abstract][Full Text] [Related]
2. Cholesteryl octanoate breath test. Preliminary studies on a new noninvasive test of human pancreatic exocrine function. Cole SG; Rossi S; Stern A; Hofmann AF Gastroenterology; 1987 Dec; 93(6):1372-80. PubMed ID: 3678753 [TBL] [Abstract][Full Text] [Related]
3. Monitoring enzyme replacement treatment in exocrine pancreatic insufficiency using the cholesteryl octanoate breath test. Mundlos S; Kühnelt P; Adler G Gut; 1990 Nov; 31(11):1324-8. PubMed ID: 2253920 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous assessments of exocrine pancreatic function by cholesteryl-[14C]octanoate breath test and measurement of plasma p-aminobenzoic acid. Bruno MJ; Hoek FJ; Delzenne B; van Leeuwen DJ; Schteingart CD; Hofmann AF; Tytgat GN Clin Chem; 1995 Apr; 41(4):599-604. PubMed ID: 7720253 [TBL] [Abstract][Full Text] [Related]
5. "Mixed" triglyceride breath test: methodological problems and clinical applications. Perri F; Andriulli A Rev Med Univ Navarra; 1998; 42(2):99-103. PubMed ID: 10420946 [TBL] [Abstract][Full Text] [Related]
6. Effects of pectin and wheat bran on intraluminal pancreatic enzyme activities and on fat absorption as examined with the triolein breath test in patients with pancreatic insufficiency. Isaksson G; Lundquist I; Akesson B; Ihse I Scand J Gastroenterol; 1984 Jun; 19(4):467-72. PubMed ID: 6205439 [TBL] [Abstract][Full Text] [Related]
7. Two-stage triolein breath test differentiates pancreatic insufficiency from other causes of malabsorption. Goff JS Gastroenterology; 1982 Jul; 83(1 Pt 1):44-6. PubMed ID: 6918337 [TBL] [Abstract][Full Text] [Related]
8. New methods for assessment of enzyme activity: do they help to optimize enzyme treatment? Adler G; Mundlos S; Kühnelt P; Dreyer E Digestion; 1993; 54 Suppl 2():3-9. PubMed ID: 7693531 [TBL] [Abstract][Full Text] [Related]
9. Measurement of extra-pancreatic secretory function by 13C-dipeptide breath test. Ishii Y; Kohno T; Ito A; Suzuki S; Kohno T; Takayama T; Asai S Transl Res; 2007 Jun; 149(6):298-303. PubMed ID: 17543847 [TBL] [Abstract][Full Text] [Related]
10. 13C labelled cholesteryl octanoate breath test for assessing pancreatic exocrine insufficiency. Ventrucci M; Cipolla A; Ubalducci GM; Roda A; Roda E Gut; 1998 Jan; 42(1):81-7. PubMed ID: 9505890 [TBL] [Abstract][Full Text] [Related]
11. Synthetic 13C-dipeptide breath test for the rapid assessment of pancreatic exocrine insufficiency in rats. Kohno T; Ito A; Hosoi I; Hirayama J; Shibata K Scand J Gastroenterol; 2007 Aug; 42(8):992-9. PubMed ID: 17613930 [TBL] [Abstract][Full Text] [Related]
12. Gastric transit and pharmacodynamics of a two-millimeter enteric-coated pancreatin microsphere preparation in patients with chronic pancreatitis. Bruno MJ; Borm JJ; Hoek FJ; Delzenne B; Hofmann AF; de Goeij JJ; van Royen EA; van Leeuwen DJ; Tytgat GN Dig Dis Sci; 1998 Jan; 43(1):203-13. PubMed ID: 9508526 [TBL] [Abstract][Full Text] [Related]
13. Comparative effects of enteric-coated pancreatin microsphere therapy after conventional and pylorus-preserving pancreatoduodenectomy. Bruno MJ; Borm JJ; Hoek FJ; Delzenne B; Hofmann AF; de Goeij JJ; van Royen EA; van Gulik TM; de Wit LT; Gouma DJ; van Leeuwen DJ; Tytgat GN Br J Surg; 1997 Jul; 84(7):952-6. PubMed ID: 9240133 [TBL] [Abstract][Full Text] [Related]
14. A new method of testing pancreatin therapy in vivo by the use of a peroral chymotrypsin substrate 4-(N-acetyl-L-tyrosyl)aminobenzoic acid. Fric P; Malis F; Kasafírek E; Slabý J Hepatogastroenterology; 1980 Jun; 27(3):220-3. PubMed ID: 6970159 [TBL] [Abstract][Full Text] [Related]
15. [Modified ALTAB test in the diagnosis of exocrine pancreatic insufficiency]. Rageh W; Klugmann HJ; Schiedewitz W; Pohl A Dtsch Z Verdau Stoffwechselkr; 1985; 45(6):307-16. PubMed ID: 3879216 [TBL] [Abstract][Full Text] [Related]
16. [Effect of pellet size of a pancreas enzyme preparation on duodenal lipolytic activity]. Kühnelt P; Mundlos S; Adler G Z Gastroenterol; 1991 Sep; 29(9):417-21. PubMed ID: 1763562 [TBL] [Abstract][Full Text] [Related]
17. Pancreatic polypeptide and exocrine pancreatic function in the elderly. al-Modaris FI; Taylor IC; McConnell JG; Power MJ; Armstrong E; Buchanan KD Ulster Med J; 1993 Apr; 62(1):44-9. PubMed ID: 8516975 [TBL] [Abstract][Full Text] [Related]
18. [Specificities of the diagnostics and therapy of exocrine pancreatic insufficiency]. Díté P; Novotny I; Kocna P; Bojková M; Kupka T; Nechutová H; Kianicka B Vnitr Lek; 2013 Jan; 59(1):65-70. PubMed ID: 23565526 [TBL] [Abstract][Full Text] [Related]
19. Liberation of 14CO2 from 14C-fatty acids by riboflavin-deficient sucking rat pups: a study of 14C-Octanoate and 14C-palmitate oxidation in vivo. Patterson BE; Bates CJ Int J Vitam Nutr Res; 1989; 59(3):293-9. PubMed ID: 2513284 [TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of fat absorption and its diagnostic value in exocrine pancreatic insufficiency. Simpson JW; Doxey DL Res Vet Sci; 1983 Sep; 35(2):249-51. PubMed ID: 6635347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]